BOTHELL, Wash. (AP) _ Seattle Genetics Inc. (SGEN) on Wednesday reported a loss of $174.6 million in its fourth quarter.

The Bothell, Washington-based company said it had a loss of 95 cents per share.

The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 79 cents per share.

The biotechnology company posted revenue of $429.9 million in the period, exceeding Street forecasts. Eight analysts surveyed by Zacks expected $403.4 million.

For the year, the company reported a loss of $674.5 million, or $3.70 per share. Revenue was reported as $1.57 billion.

Seattle Genetics expects full-year revenue in the range of $1.67 billion to $1.75 billion.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SGEN at https://www.zacks.com/ap/SGEN

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News